AVXL - Anavex initiates Phase 2 study for schizophrenia drug candidate
2024-01-16 16:46:59 ET
More on Anavex Life Sciences
- Anavex: The Pediatric Rett Trial Failure Is Disastrous
- How Soon Might Anavex's Alzheimer's Drug Be Approved? The Good/Bad News
- Anavex Life Sciences: Rett Safety Dance With Broader CNS Implications (Rating Downgrade)
- Anavex drops as Phase 2/3 trial for Rett syndrome candidate fails
- Anavex gets EMA green light to submit blarcamesine application for Alzheimer's
For further details see:
Anavex initiates Phase 2 study for schizophrenia drug candidate